Severe Malaria News & Events

0

News

Strides Shasun’s rectal artesunate product receives WHO prequalification

WHO provides first-ever approval for rectal artesunate product for severe malaria

WHO information note on correct use of rectal artesunate for severe malaria

100 million vials of injectable artesunate distributed since 2010

New partnership announced to tackle severe malaria in rural Zambia

Rectal artesunate listed as essential medicine

New malaria research project to improve maternal and child health

Cipla’s artesunate suppository first to be quality-assured by Global Fund

Success treating severe malaria in Nigeria

DRC: 40,000 people treated for malaria as disease surges

South Sudan: On pace for a second, exceptionally severe malaria season

Pages

0

Events

View all events